Squarepoint

Squarepoint’s Vir Biotechnology VIR Stock Holding History

Squarepoint’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$233K	Buy	26,013 +5,146	+25%	+$41K	﹤0.01%	3875
2025 Q4	$126K	Sell	20,867 -256,448	-92%	-$1.53M	﹤0.01%	3995
2025 Q3	$1.58M	Buy	277,315 +169,955	+158%	+$869K	﹤0.01%	2291
2025 Q2	$541K	Buy	107,360 +53,662	+100%	+$288K	﹤0.01%	3201
2025 Q1	$348K	Sell	53,698 -160,565	-75%	-$1.43M	﹤0.01%	3621
2024 Q4	$1.57M	Buy	214,263 +110,563	+107%	+$872K	﹤0.01%	2632
2024 Q3	$777K	Buy	103,700 +50,290	+94%	+$437K	﹤0.01%	2796
2024 Q2	$475K	Buy	+53,410	New	+$512K	﹤0.01%	3118
2024 Q1	–	Sell	-221,855	Closed	-$2.23M	–	4760
2023 Q4	$2.23M	Buy	221,855 +49,214	+29%	+$450K	0.01%	1920
2023 Q3	$1.62M	Buy	+172,641	New	+$2.46M	0.01%	1979
2022 Q3	–	Sell	-70,630	Closed	-$1.8M	–	3528
2022 Q2	$1.8M	Sell	70,630 -48,578	-41%	-$1.13M	0.02%	1261
2022 Q1	$3.07M	Buy	119,208 +95,737	+408%	+$2.84M	0.02%	918
2021 Q4	$983K	Buy	+23,471	New	+$920K	﹤0.01%	1708
2021 Q2	–	Sell	-16,178	Closed	-$829K	–	3741
2021 Q1	$829K	Buy	+16,178	New	+$872K	0.01%	1655
2020 Q1	–	Sell	-13,234	Closed	-$166K	–	2564
2019 Q4	$166K	Buy	+13,234	New	+$177K	﹤0.01%	2263

Other funds holding VIR

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

GSK plc London $599M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return